Indian Company Moves To Provide Affordable Insulin Biosimilar In Europe As Patents Rise
Bangalore-based Biocon may become the first Indian company to offer a biosimilar insulin in Europe. And the patent and pricing story is interesting.
Intellectual Property Watch
Original news and analysis on international IP policy
Tatum Anderson
Paediatric Cancer Drug Being Developed Entirely In The Open
The term “Open” in science is all the rage these days.
EU Eyes Revamp Of Policy To Speed Drug Approvals In Developing Countries
Article 58, a process introduced by the European Commission to help speed up the time low and middle-income countries take to approve new drugs, could be in for a massive overhaul. A revamp has been proposed because it is underused - just a handful of products have gone through the Article 58 process since its launch in 2004. The most recent is an antiseptic chlorhexidine gel that prevents new-born umbilical cord infections in developing countries. A joint project between GSK and Save the Children, it was approved late last month.
New US Voucher Prize System For Neglected Diseases Launches Amid Doubts
By Tatum Anderson for Intellectual Property Watch As a novel prize system to encourage the development of treatments for diseases that disproportionately affect patients in developing countries launches in the United States next month, concerns are already being voiced as…
Nokia-Qualcomm Settlement Boosts Sharing, Ends Costly Patent War
By Tatum Anderson for Intellectual Property Watch Nokia and Qualcomm, the two mobile phone equipment manufacturers engaged in a costly patent war that spanned three years and three continents settled their differences last week. However, questions still remain over the…
All Eyes On Latest Qualcomm-Nokia Court Battle’s Impact On Patents And Licensing
By Tatum Anderson for Intellectual Property Watch
An important court case in the ongoing saga between two of the mobile industry's most influential technology firms begins next week.
The case is a crucial stage in the ongoing disagreement between the two equipment manufacturers - Finnish Nokia and US Qualcomm - that has become increasingly acrimonious over recent years and resulted in numerous patent infringement cases all over the world.
US, Indian HIV/AIDS Drug Rulings Could Reverberate In Brazil
By Tatum Anderson for Intellectual Property Watch Indian generic manufacturers may be allowed to export a cheaper HIV/AIDS treatment to middle-income countries if US pharmaceutical company Gilead fails to win a patent for the drug in India. And a turnaround…
Mobile Phone Manufacturers Seek To Control Rising IP Costs
By Tatum Anderson for Intellectual Property Watch
A proposal by some of the world's largest mobile phone equipment manufacturers to limit royalty fees on a next-generation wireless technology is the latest in a series of initiatives to try and control spiralling intellectual property costs.
India Cancer Patients Seek To Use Courts For Access To Patented Drugs
By Tatum Anderson for Intellectual Property Watch One of the most vocal voices for the interests of cancer patients in India says it will use the courts to force the Indian government to declare cancer a national emergency, in an…
Tussle Over Participation In India Compulsory Licence Hearing
By Tatum Anderson for Intellectual Property Watch Swiss pharmaceutical company Roche is expected to appear before the Indian Patent Office on 17 March to assert its right to attend a later meeting that could result in one of its drugs…